PGC’s Immunogenomic Surveillance Program (IGSP) project 1 completion: Genomic and Clinical Characterization of SARS-CoV-2 Variant P.3 in the Philippines

Nationwide genomic biosurveillance The routine genomic biosurveillance for SARS-CoV-2 in the Philippines through the Philippine Genome Center (PGC), in coordination with the Department of Health (DOH) – Epidemiology Bureau and the Inter-Agency Task Force (IATF) Task Force on COVID-19 Variants began during the last week of December 2020 with the confirmation of VoC (Variant of […]